share_log

完美醫療:股份發行人的證券變動月報表截至二零二三年十二月三十一日

PERFECT MEDICAL: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 2 04:35
Summary by Moomoo AI
完美醫療健康管理有限公司於2024年1月2日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示,公司的法定/註冊股本及已發行股份在該月份均無變動,維持在10,000,000,000股,每股面值0.1港元,總額1,000,000,000港元。此外,根據公司的股份期權計劃,本月內已授出3,768,000股份期權,但本月內無新股份發行。公司確認所有相關上市規則的要求均已遵守,並無其他未披露的證券變動。
完美醫療健康管理有限公司於2024年1月2日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示,公司的法定/註冊股本及已發行股份在該月份均無變動,維持在10,000,000,000股,每股面值0.1港元,總額1,000,000,000港元。此外,根據公司的股份期權計劃,本月內已授出3,768,000股份期權,但本月內無新股份發行。公司確認所有相關上市規則的要求均已遵守,並無其他未披露的證券變動。
Perfect Healthcare Management Limited filed with Hong Kong Trading and Settlement Limited on 2 January 2024 with Hong Kong Trading and Settlement Holdings Limited the Monthly Securities Change Report for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 10,000,000,000 shares with a face value of HK$0.1 per share for a total of HK$1,000,000,000. In addition, 3,768,000 share options were granted under the Company's stock option plan this month, but no new shares were issued this month. The Company confirms that all relevant listing rules requirements have been complied with and that there are no other undisclosed securities changes.
Perfect Healthcare Management Limited filed with Hong Kong Trading and Settlement Limited on 2 January 2024 with Hong Kong Trading and Settlement Holdings Limited the Monthly Securities Change Report for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 10,000,000,000 shares with a face value of HK$0.1 per share for a total of HK$1,000,000,000. In addition, 3,768,000 share options were granted under the Company's stock option plan this month, but no new shares were issued this month. The Company confirms that all relevant listing rules requirements have been complied with and that there are no other undisclosed securities changes.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more